@techcrunch.com 2 years ago
Amazon is now selling its own Covid-19 test kits for $39.99 in the U.S.
@techcrunch.com 4 years ago
With echoes of Theranos, Truvian Sciences revives the dream of low-cost, accessible blood tests
@techcrunch.com 4 years ago
Lucence raises $20 million Series A for its non-invasive cancer screening technology
@techcrunch.com 4 years ago
Verily, Alphabet’s other money-making, non-Google business, partners with Color on genetic analysis
@techcrunch.com 4 years ago
Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million
@techcrunch.com 5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@techcrunch.com 5 years ago
Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests
@techcrunch.com 7 years ago
23andMe is finally allowed to tell you if you have the genes for Parkinsons
@techcrunch.com 7 years ago
Carbon Health wants to put medical data in one place for patients and their many doctors
@techcrunch.com 7 years ago
Theranos reportedly voids two years of reports from its Edison blood-testing devices
@techcrunch.com 8 years ago
Scanadu Raises $35M Series B To Check Your Pee And Scan Your Vitals
@techcrunch.com 9 years ago
Apple Introduces ResearchKit, Turning iPhones Into Medical Diagnostic Devices